164 related articles for article (PubMed ID: 37304234)
1. LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.
Jin Y; Qiu J; Lu X; Ma Y; Li G
Oncol Res; 2023; 31(2):169-179. PubMed ID: 37304234
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
3. C-MYC Inhibited Ferroptosis and Promoted Immune Evasion in Ovarian Cancer Cells through NCOA4 Mediated Ferritin Autophagy.
Jin Y; Qiu J; Lu X; Li G
Cells; 2022 Dec; 11(24):. PubMed ID: 36552889
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.
Cai L; Hu X; Ye L; Bai P; Jie Y; Shu K
Bioengineered; 2022 Apr; 13(4):8226-8239. PubMed ID: 35311457
[TBL] [Abstract][Full Text] [Related]
5. NSUN5-FTH1 Axis Inhibits Ferroptosis to Promote the Growth of Gastric Cancer Cells.
Su Y; Liu J; Zheng Z; Shi L; Huang W; Huang X; Ye C; Qi J; Wang W; Zhuang H
Cell Biochem Biophys; 2023 Sep; 81(3):553-560. PubMed ID: 37528314
[TBL] [Abstract][Full Text] [Related]
6. SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.
Zhu Y; Yang L; Wang J; Li Y; Chen Y
J Gynecol Oncol; 2022 Nov; 33(6):e75. PubMed ID: 36245227
[TBL] [Abstract][Full Text] [Related]
7. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
8. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m
Zheng J; Zhang Q; Zhao Z; Qiu Y; Zhou Y; Wu Z; Jiang C; Wang X; Jiang X
J Exp Clin Cancer Res; 2023 May; 42(1):127. PubMed ID: 37202791
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
10. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
11. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.
Tian Y; Lu J; Hao X; Li H; Zhang G; Liu X; Li X; Zhao C; Kuang W; Chen D; Zhu M
Neurotherapeutics; 2020 Oct; 17(4):1796-1812. PubMed ID: 32959272
[TBL] [Abstract][Full Text] [Related]
12. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
Wei LJ; Bai DM; Wang ZY; Liu BC
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.
Yu PF; Kang AR; Jing LJ; Wang YM
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
Yang J; Li C; Li H; E C
J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
20. TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.
Gong H; Gao M; Lin Y; Liu J; Hu Z; Liu J
Oxid Med Cell Longev; 2022; 2022():7843863. PubMed ID: 36164395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
